bluebird bio Inc (BLUE)
1.005
0.00 (0.00%)
USD |
NASDAQ |
May 07, 10:20
bluebird bio SG&A Expense (Quarterly): 40.70M for Sept. 30, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 40.70M |
June 30, 2023 | 40.35M |
March 31, 2023 | 37.35M |
December 31, 2022 | 30.71M |
September 30, 2022 | 33.40M |
June 30, 2022 | 36.69M |
March 31, 2022 | 36.11M |
December 31, 2021 | 53.21M |
September 30, 2021 | 42.23M |
June 30, 2021 | 54.98M |
March 31, 2021 | 63.57M |
December 31, 2020 | 30.03M |
September 30, 2020 | 68.05M |
June 30, 2020 | 68.63M |
March 31, 2020 | 73.25M |
December 31, 2019 | 40.68M |
September 30, 2019 | 66.25M |
June 30, 2019 | 68.63M |
March 31, 2019 | 60.28M |
December 31, 2018 | 53.51M |
September 30, 2018 | 44.53M |
June 30, 2018 | 41.17M |
March 31, 2018 | 34.93M |
December 31, 2017 | 29.09M |
Date | Value |
---|---|
September 30, 2017 | 22.98M |
June 30, 2017 | 21.20M |
March 31, 2017 | 20.28M |
December 31, 2016 | 16.18M |
September 30, 2016 | 14.62M |
June 30, 2016 | 18.36M |
March 31, 2016 | 15.96M |
December 31, 2015 | 14.44M |
September 30, 2015 | 13.70M |
June 30, 2015 | 10.72M |
March 31, 2015 | 7.336M |
December 31, 2014 | 5.303M |
September 30, 2014 | 6.648M |
June 30, 2014 | 5.738M |
March 31, 2014 | 5.54M |
December 31, 2013 | 4.685M |
September 30, 2013 | 3.836M |
June 30, 2013 | 3.281M |
March 31, 2013 | 2.324M |
December 31, 2012 | 2.544M |
September 30, 2012 | 1.608M |
June 30, 2012 | 1.331M |
March 31, 2012 | 1.363M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
30.03M
Minimum
Dec 2020
73.25M
Maximum
Mar 2020
49.16M
Average
41.47M
Median
SG&A Expense (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 369.10M |
Novavax Inc | 155.24M |
Motus GI Holdings Inc | 1.689M |
Tivic Health Systems Inc | 1.889M |
AIM ImmunoTech Inc | 10.86M |